Literature DB >> 28662823

Matrix Metalloproteinases in Bone Resorption, Remodeling, and Repair.

Katiucia B S Paiva1, José M Granjeiro2.   

Abstract

Matrix metalloproteinases (MMPs) are the major protease family responsible for the cleavage of the matrisome (global composition of the extracellular matrix (ECM) proteome) and proteins unrelated to the ECM, generating bioactive molecules. These proteins drive ECM remodeling, in association with tissue-specific and cell-anchored inhibitors (TIMPs and RECK, respectively). In the bone, the ECM mediates cell adhesion, mechanotransduction, nucleation of mineralization, and the immobilization of growth factors to protect them from damage or degradation. Since the first description of an MMP in bone tissue, many other MMPs have been identified, as well as their inhibitors. Numerous functions have been assigned to these proteins, including osteoblast/osteocyte differentiation, bone formation, solubilization of the osteoid during bone resorption, osteoclast recruitment and migration, and as a coupling factor in bone remodeling under physiological conditions. In turn, a number of pathologies, associated with imbalanced bone remodeling, arise mainly from MMP overexpression and abnormalities of the ECM, leading to bone osteolysis or bone formation. In this review, we will discuss the functions of MMPs and their inhibitors in bone cells, during bone remodeling, pathological bone resorption (osteoporosis and bone metastasis), bone repair/regeneration, and emergent roles in bone bioengineering.
© 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Biomaterials; Bone bioengineering; Bone regeneration; Bone remodeling; Bone repair; Bone resorption; Extracellular matrix; Matrix metalloproteinases (MMPs); Mesenchymal stem cells; Tissue inhibitors of matrix metalloproteinases (TIMPs)

Mesh:

Substances:

Year:  2017        PMID: 28662823     DOI: 10.1016/bs.pmbts.2017.05.001

Source DB:  PubMed          Journal:  Prog Mol Biol Transl Sci        ISSN: 1877-1173            Impact factor:   3.622


  46 in total

1.  Osteoclast-mediated bone resorption is controlled by a compensatory network of secreted and membrane-tethered metalloproteinases.

Authors:  Lingxin Zhu; Yi Tang; Xiao-Yan Li; Evan T Keller; Jingwen Yang; Jung-Sun Cho; Tamar Y Feinberg; Stephen J Weiss
Journal:  Sci Transl Med       Date:  2020-02-05       Impact factor: 17.956

Review 2.  Supramolecular Peptide Nanofiber Hydrogels for Bone Tissue Engineering: From Multihierarchical Fabrications to Comprehensive Applications.

Authors:  Zhuowen Hao; Hanke Li; Yi Wang; Yingkun Hu; Tianhong Chen; Shuwei Zhang; Xiaodong Guo; Lin Cai; Jingfeng Li
Journal:  Adv Sci (Weinh)       Date:  2022-02-07       Impact factor: 16.806

Review 3.  Poor bone matrix quality: What can be done about it?

Authors:  Asier Muñoz; Anxhela Docaj; Maialen Ugarteburu; Alessandra Carriero
Journal:  Curr Osteoporos Rep       Date:  2021-08-20       Impact factor: 5.096

4.  Extracellular vesicles derived from bone marrow mesenchymal stem cells loaded on magnetic nanoparticles delay the progression of diabetic osteoporosis via delivery of miR-150-5p.

Authors:  Chen Xu; Zhaodong Wang; Yajun Liu; Bangguo Wei; Xiangyu Liu; Keyou Duan; Pinghui Zhou; Zhao Xie; Min Wu; Jianzhong Guan
Journal:  Cell Biol Toxicol       Date:  2022-09-16       Impact factor: 6.819

Review 5.  Tissue engineered bone mimetics to study bone disorders ex vivo: Role of bioinspired materials.

Authors:  Yuru Vernon Shih; Shyni Varghese
Journal:  Biomaterials       Date:  2018-06-06       Impact factor: 12.479

6.  Nobiletin-loaded micelles reduce ovariectomy-induced bone loss by suppressing osteoclastogenesis.

Authors:  Yabing Wang; Jian Xie; Zexin Ai; Jiansheng Su
Journal:  Int J Nanomedicine       Date:  2019-09-26

7.  Combination of endothelial progenitor cells and BB-94 significantly alleviates brain damage in a mouse model of diabetic ischemic stroke.

Authors:  Daixuan Zhou; Zhi Huang; Xiaoxi Zhu; Tao Hong; Yuanli Zhao
Journal:  Exp Ther Med       Date:  2021-05-21       Impact factor: 2.447

8.  18β-Glycyrrhetinic Acid Inhibits Osteoclastogenesis In Vivo and In Vitro by Blocking RANKL-Mediated RANK-TRAF6 Interactions and NF-κB and MAPK Signaling Pathways.

Authors:  Xiao Chen; Xin Zhi; Zhifeng Yin; Xiaoqun Li; Longjuan Qin; Zili Qiu; Jiacan Su
Journal:  Front Pharmacol       Date:  2018-06-20       Impact factor: 5.810

Review 9.  The hypertrophic chondrocyte: To be or not to be.

Authors:  Shawn A Hallett; Wanida Ono; Noriaki Ono
Journal:  Histol Histopathol       Date:  2021-06-17       Impact factor: 2.303

10.  ADAMTS5 is required for normal trabeculated bone development in the mandibular condyle.

Authors:  A W Rogers-DeCotes; S C Porto; L E Dupuis; C B Kern
Journal:  Osteoarthritis Cartilage       Date:  2021-02-06       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.